Physician Investigator (Cl)
Cancer Center,
Mass General Research Institute
|
Assistant Professor of Medicine
Harvard Medical School
|
PhD 2001 |
MD Albert Einstein college of medicine 2001 |
anilides; biomarkers in prostate cancer; bone neoplasms; cabozantinib; circulating tumor cells; osteoblasts; osteoclasts; prostate cancer; prostatic neoplasms; proto-oncogene proteins c-met; rank ligand; receptors vascular endothelial growth factor; renal cell carcinoma
Since joining the staff at MGH, Dr. Lee has been engaged in translational studies of circulating tumor cells (CTCs) from peripheral blood, using a new technology developed at MGH. Our hope is that this "CTC-Chip" may have clinical usefulness for cancer patients. In addition to seeing patients, Dr. Lee is also interested in clinical trials of new drugs to treat genitourinary cancers.